Psilocybin for Major Depressive Disorder (MDD)
Researchers are comparing Psilocybin 25 mg, Psilocybin 5 mg and placebo to find out how the approaches affect depression symptoms in adults with depression.
Understand this study
What is this study about?
Researchers are comparing Psilocybin 25 mg, Psilocybin 5 mg and placebo to find out how the approaches affect depression symptoms in adults with depression.
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Birmingham and 28 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 238
- Sponsor
- Usona Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06308653
- Official title
Show the full official title
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)
Recruitment & locations
Birmingham · Fayetteville · Little Rock
25 more locations
- La Jolla
- Los Angeles
- Santa Monica
- Denver
- New Haven
- Jacksonville
- Lauderhill
- Orlando
- Atlanta
- Decatur
- Chicago
- Baltimore
- Rockville
- St Louis
- Omaha
- Princeton
- Albuquerque
- New York
- The Bronx
- Plano
- San Antonio
- Draper
- Murray
- Bellevue
- Vancouver
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing Psilocybin 25 mg, Psilocybin 5 mg and placebo to find out how the approaches affect depression symptoms in adults with depression.
Who is behind this study?
The study sponsor is Usona Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin 25 mg, Inactive Placebo and Psilocybin 5 mg.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
